BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 22753693)

  • 1. Primary isoniazid resistance in Mycobacterium bovis disease: a prospect of concern.
    McLaughlin AM; Gibbons N; Fitzgibbon M; Power JT; Foley SC; Hayes JP; Rogers T; Keane J
    Am J Respir Crit Care Med; 2012 Jul; 186(1):110-1. PubMed ID: 22753693
    [No Abstract]   [Full Text] [Related]  

  • 2. [Place of bacteriological examination in the treatment of tuberculosis].
    Gyselen A
    Acta Tuberc Pneumol Belg; 1972; 63(4):405-8. PubMed ID: 4206438
    [No Abstract]   [Full Text] [Related]  

  • 3. Tuberculosis in Acukland.
    Swinburn PD
    N Z Med J; 1973 Dec; 78(505):520-5. PubMed ID: 4205888
    [No Abstract]   [Full Text] [Related]  

  • 4. [Reasons for drug-resistant tuberculosis emergence].
    Tu DH
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):403-5. PubMed ID: 17673006
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia.
    Toungoussova S; Caugant DA; Sandven P; Mariandyshev AO; Bjune G
    Int J Tuberc Lung Dis; 2002 May; 6(5):406-14. PubMed ID: 12019916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of susceptibility of Mycobacterium bovis to antituberculous drugs by radiometric BACTEC 460TB system.
    Cavirani S; Fanti F; Benecchi M; Calderaro A; Taddei S; Arcangeletti C; Medici MC; Dettori G; Chezzi C
    New Microbiol; 2003 Apr; 26(2):181-6. PubMed ID: 12737201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pulmonary tuberculosis caused by Mycobacterium bovis with primary resistance to Isoniazide and pyrazinamide].
    Blanco Ramos JR; Rosel Rioja L; Dopereiro Gómez R; Oteo Revuelta JA
    An Med Interna; 1997 Aug; 14(8):433-4. PubMed ID: 9376493
    [No Abstract]   [Full Text] [Related]  

  • 8. Primary tuberculosis in children. 1. Incidence of primary drug-resistant disease in 332 children observed between the years 1961 and 1964 at the Kings County Medical Center of Brooklyn.
    Steiner M; Cosio A
    N Engl J Med; 1966 Apr; 274(14):755-9. PubMed ID: 17926880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
    Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
    Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rifampin-resistant Mycobacterium bovis BCG-induced disease in HIV-infected infant, Vietnam.
    Hong DN; Huyen MN; Lan NT; Duong NH; Ngo VV; Ngoc DT; Huu KT; Nguyen T; Do Chau V; Marcy O; Van de Perre P; Bañuls AL; Godreuil S
    Emerg Infect Dis; 2013 Jul; 19(7):1168-70. PubMed ID: 23764043
    [No Abstract]   [Full Text] [Related]  

  • 11. Epidemiology of Mycobacterium bovis disease in humans, The Netherlands, 1993-2007.
    Majoor CJ; Magis-Escurra C; van Ingen J; Boeree MJ; van Soolingen D
    Emerg Infect Dis; 2011 Mar; 17(3):457-63. PubMed ID: 21392437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and management of tuberculosis.
    Harris AA; Karakusis P
    Prim Care; 1979 Mar; 6(1):43-62. PubMed ID: 111269
    [No Abstract]   [Full Text] [Related]  

  • 13. Advances in the treatment of tuberculosis.
    Clarke PD
    J R Nav Med Serv; 1976; 62(2):85-91. PubMed ID: 61273
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug-resistance tuberculosis among the foreign-born in Canada.
    Can Commun Dis Rep; 2005 Feb; 31(4):46-52. PubMed ID: 15712449
    [No Abstract]   [Full Text] [Related]  

  • 15. Detection of and treatment protocol for rifampicin-monoresistant tuberculosis: what is the role of isoniazid?
    Velayati AA; Farnia P; Masjedi MR; Hoffner S
    Int J Tuberc Lung Dis; 2013 Jun; 17(6):849-50. PubMed ID: 23676176
    [No Abstract]   [Full Text] [Related]  

  • 16. Resistant Mycobacterium bovis Bacillus Calmette-Guérin disease: implications for management of Bacillus Calmette-Guérin Disease in human immunodeficiency virus-infected children.
    Hesseling AC; Schaaf HS; Victor T; Beyers N; Marais BJ; Cotton MF; Wiid I; Gie RP; van Helden P; Warren RM
    Pediatr Infect Dis J; 2004 May; 23(5):476-9. PubMed ID: 15131480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lupus vulgaris caused by Mycobacterium bovis].
    Jaka-Moreno A; López-Núñez M; López-Pestaña A; Tuneu-Valls A
    Actas Dermosifiliogr; 2012 Apr; 103(3):251-3. PubMed ID: 22056255
    [No Abstract]   [Full Text] [Related]  

  • 18. Increasing drug resistance of Mycobacterium tuberculosis isolates in Ontario, Canada, 1987-1998.
    Remis RS; Jamieson F; Chedore P; Haddad A; Vernich L
    Clin Infect Dis; 2000 Aug; 31(2):427-32. PubMed ID: 10987700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bactericidal therapy in patients with tuberculosis].
    Krasnov VA; Ursov IG
    Probl Tuberk Bolezn Legk; 2004; (3):21-6. PubMed ID: 15338895
    [No Abstract]   [Full Text] [Related]  

  • 20. Tuberculosis in Australia: bacteriologically confirmed cases and drug resistance, 2002: a report of the Australian Mycobacterium Reference Laboratory Network.
    Lumb R; Bastian I; Chew W; Gilpin C; Haverkort F; James G; Sievers A
    Commun Dis Intell Q Rep; 2003; 27(4):459-65. PubMed ID: 15508499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.